Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Corning Incorporated (GLW) -- Ignore unavailable to you. Want to Upgrade?

To: profile_14 who wrote (1388)	7/6/2001 2:44:37 PM
From: Frederick Langford	Read Replies (1) \| Respond to of 2260

BioDiscovery, Inc. and Corning Incorporated Sign Co-Marketing Agreement LOS ANGELES, Jul 6, 2001 /PRNewswire via COMTEX/ -- BioDiscovery, Inc. a leading developer of software products for microarrays, announced today that it has signed a non-exclusive co-marketing agreement with Corning Incorporated, a world leader in optical communications and more recently a major contributor to the microarray market. Under terms of the agreement BioDiscovery and Corning will co-market BioDiscovery's market leading software products for microarray analysis and Corning's gene arrays. "BioDiscovery is committed to offering our customers state-of-art software for microarrays and we see this co-marketing agreement consistent with this objective," said Dr. Soheil Shams, president of BioDiscovery. Under the agreement BioDiscovery will add templates for Corning's gene arrays to the BioDiscovery ImaGene(TM) product family. ImaGene is widely recognized as the industry leading software for microarray image analysis and quantitation." "Corning Incorporated is known not only for its world class manufacturing capabilities, but also its innovative business solutions that will ultimately benefit our customers," states John Lubniewski, director of sales and marketing for Corning Microarray Technologies. "We believe that this is one of many steps which will ensure building strong relationships up and down the value chain and at the same time offer a complete solution to our customers. This co-marketing effort will allow Corning customers the benefit of having an open format, and will promote ease of use for those who are using ImaGene software." About the companies: Established in 1851, Corning Incorporated (www.corning.com) creates leading-edge technologies for the fastest-growing markets of the world's economy. Corning manufactures optical fiber, cable and photonic products for the telecommunications industry; and high-performance displays and components for television, information technology and other communications-related industries. The company also uses advanced materials to manufacture products for scientific, semiconductor, environmental and life science markets. Corning's revenues in 2000 were $ 7.1 billion. Corning launched its first commercial DNA microarray, the CMT(TM) Yeast S228c gene array, in September of last year, and intends to expand its product portfolio with both index and theme arrays for multiple organisms in 2001. These new products build upon the success of Corning's CMT-GAPS(TM) coated slides, hybridization chambers, as well as its existing glass and plastic laboratory ware business. ( corning.com ) BioDiscovery, Inc., based in Los Angeles, CA is the leading developer of software products for microarrays. BioDiscovery's product line consists of CloneTracker(TM), ImaGene(TM), and GeneSight(TM). For more information on BioDiscovery's products see www.biodiscovery.com.

To: profile_14 who wrote (1388)	5/2/2006 5:59:46 PM
From: hubris33	Respond to of 2260

Profile, Not certain if your note is a polite way of pointing out a couple of stocks worthy of play or not? On a side note, I have not shorted much and that which I have done has been off of pullbacks into falling MAs. I saw some news about the Bolivian situation and from a FA point that might have some effect, though others got hit hard today. Top picking looks as hard as bottom picking or catching the falling knife. On the B play the gap up is intriguing especially because of the average volume. However I note that RSI isn't o/s yet and MACD is about to cross up, although divergent with the high today. Certainly a 50% gain so far this year could use a blow off. Maybe the March-April period is a fractal of January? We have tweezer tops here that if breached could lead higher. Of course a failure to breach might present some downside opportunity. What do you see that intrigues? I'm eager to learn the 'dark side.' H3 Sorry for this post - no priv mail capabilities so I use this method.